आईएसएसएन: 2329-8790
Eric Adebiyi*
Iron Deficiency Anaemia (IDA) is a common nutritional disorder affecting pregnant women, with significant implications for both maternal and fetal health. The management of IDA during pregnancy involves the supplementation of iron, either through oral or intravenous routes. This research article aims to comprehensively analyze and compare the efficacy, safety, and clinical outcomes of Intravenous (IV) iron administration against oral iron supplementation for the treatment of iron deficiency anaemia in pregnancy. A systematic review of available literature, including Randomized Controlled Trials (RCTs), cohort studies, and meta-analyses, was conducted. The results indicate that both IV and oral iron regimens have their merits and limitations, impacting factors such as haemoglobin levels, maternal symptoms, birth outcomes, and adverse events. The analysis considers maternal preferences, healthcare infrastructure, and economic factors that influence the choice of iron supplementation. The findings of this study provide evidence-based insights for clinicians and healthcare providers to make informed decisions when selecting the most appropriate iron supplementation method for managing iron deficiency anaemia in pregnant women.